Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,970 | 146 | 99.4% |
| Education | $11.90 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $885.32 | 73 | $0 (2024) |
| Lilly USA, LLC | $200.47 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $170.35 | 13 | $0 (2023) |
| PFIZER INC. | $129.38 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.38 | 6 | $0 (2022) |
| Abbott Laboratories | $67.58 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $60.87 | 4 | $0 (2021) |
| Amgen Inc. | $59.75 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $50.54 | 3 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $40.58 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.36 | 3 | PFIZER INC. ($33.64) |
| 2023 | $171.25 | 9 | Lilly USA, LLC ($42.53) |
| 2022 | $231.32 | 17 | Novo Nordisk Inc ($136.13) |
| 2021 | $228.70 | 16 | Novo Nordisk Inc ($147.21) |
| 2020 | $133.36 | 10 | Novo Nordisk Inc ($78.40) |
| 2019 | $545.77 | 45 | Novo Nordisk Inc ($222.67) |
| 2018 | $360.74 | 27 | Novo Nordisk Inc ($129.65) |
| 2017 | $257.93 | 20 | Novo Nordisk Inc ($120.82) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: PAIN | ||||||
| 04/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: PAIN | ||||||
| 03/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 11/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Diabetes Care | ||||||
| 06/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Diabetes | ||||||
| 06/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: PSYCHIATRY | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/18/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 04/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes Care | ||||||
| 04/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Diabetes | ||||||
| 04/06/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Inflammation | ||||||
| 12/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Cardio-renal | ||||||
| 11/21/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes | ||||||
| 10/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Diabetes | ||||||
| 08/09/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 06/23/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 05/05/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes | ||||||
| 04/14/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Diabetes Care | ||||||
| 04/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 803 | 2,129 | $145,553 | $71,467 |
| 2022 | 17 | 705 | 2,603 | $138,962 | $73,734 |
| 2021 | 19 | 786 | 1,391 | $112,918 | $63,708 |
| 2020 | 14 | 709 | 1,529 | $109,639 | $47,545 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 453 | $85,380 | $35,483 | 41.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 720 | $17,250 | $11,843 | 68.7% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 110 | 112 | $8,064 | $4,430 | 54.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 45 | 73 | $4,978 | $3,319 | 66.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $4,050 | $3,102 | 76.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 35 | $2,800 | $2,518 | 89.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 211 | $6,330 | $1,937 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 36 | $4,530 | $1,825 | 40.3% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 11 | 11 | $1,680 | $1,573 | 93.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $1,650 | $1,368 | 82.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 20 | 21 | $1,380 | $800.70 | 58.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 23 | $1,506 | $798.93 | 53.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $1,040 | $496.47 | 47.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 14 | 14 | $560.00 | $468.86 | 83.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 27 | 27 | $810.00 | $451.44 | 55.7% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 11 | 11 | $605.00 | $418.00 | 69.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 26 | 49 | $490.00 | $223.41 | 45.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 16 | $400.00 | $143.83 | 36.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 35 | 125 | $1,250 | $128.01 | 10.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 42 | 56 | $560.00 | $123.20 | 22.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 48 | $240.00 | $18.64 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 460 | $74,085 | $37,834 | 51.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 15 | 1,260 | $31,500 | $20,421 | 64.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 88 | $9,160 | $4,383 | 47.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 84 | 225 | $6,750 | $1,929 | 28.6% |
About Dr. Margaret Belue, MD
Dr. Margaret Belue, MD is a Family Medicine healthcare provider based in Scottsboro, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2009. The National Provider Identifier (NPI) number assigned to this provider is 1669601456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Margaret Belue, MD has received a total of $1,981 in payments from pharmaceutical and medical device companies, with $52.36 received in 2024. These payments were reported across 147 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,970).
As a Medicare-enrolled provider, Belue has provided services to 3,003 Medicare beneficiaries, totaling 7,652 services with total Medicare billing of $256,454. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Scottsboro, AL
- Active Since 07/14/2009
- Last Updated 10/03/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1669601456
Products in Payments
- Ozempic (Drug) $420.51
- FARXIGA (Drug) $158.98
- TRULICITY (Drug) $141.52
- Victoza (Drug) $137.28
- Rybelsus (Drug) $125.57
- Tresiba (Drug) $85.58
- TRADJENTA (Drug) $58.15
- ELIQUIS (Drug) $56.05
- FREESTYLE LIBRE 2 (Device) $54.60
- Saxenda (Drug) $51.68
- XARELTO (Drug) $50.54
- Levemir (Drug) $48.63
- TOUJEO (Drug) $47.07
- MOUNJARO (Drug) $42.53
- CHANTIX (Drug) $41.12
- AJOVY (Drug) $40.58
- Aimovig (Biological) $37.59
- Belviq (Drug) $36.48
- NURTEC ODT (Drug) $33.64
- Kerendia (Drug) $28.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Scottsboro
Mandi Allen-Bell, Md, MD
Family Medicine — Payments: $17,164
Dr. Charles Bradford, M.d, M.D
Family Medicine — Payments: $9,263
Dr. Charles Bradford, M.d, M.D
Family Medicine — Payments: $8,882
Mark Cooper, M.d, M.D
Family Medicine — Payments: $2,453
Christopher Clayton, M.d, M.D
Family Medicine — Payments: $1,865
Dr. John Tucker, M.d, M.D
Family Medicine — Payments: $1,411